Intraocular lymphoma following a primary testicular lymphoma in remission for 10 years.
Aliferis
K
K
Clinique d'Ophtalmologie de Genève-Hôpitaux Universitaires de Genève, Rue Alcide-Jentzer, 22, Bethesda, 1205, Geneva, Switzerland.
Chan
C C
CC
Donati
G
G
Baglivo
E
E
D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D004797:Enzyme-Linked Immunosorbent Assay; D005128:Eye Diseases / Q000175:diagnosis*; D005451:Fluorescein Angiography; D006801:Humans; D016753:Interleukin-10 / Q000032:analysis; D016393:Lymphoma, B-Cell / Q000473:pathology* / Q000628:therapy; D008297:Male; D009919:Orchiectomy; D016133:Polymerase Chain Reaction; D011241:Prednisone / Q000627:therapeutic use; D012074:Remission Induction; D019572:Retinal Neoplasms / Q000175:diagnosis / Q000556:secondary*; D013736:Testicular Neoplasms / Q000473:pathology* / Q000628:therapy; D014750:Vincristine / Q000627:therapeutic use; D014821:Vitrectomy; D014822:Vitreous Body / Q000473:pathology*
D016753:Interleukin-10; D014750:Vincristine; D004317:Doxorubicin; D003520:Cyclophosphamide; D011241:Prednisone